| Serial Number | 79179755 |
| Word Mark | PORTON BIOPHARMA |
| Filing Date | Friday, September 4, 2015 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, April 12, 2024 |
| Registration Number | 5293334 |
| Registration Date | Tuesday, September 26, 2017 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 11, 2017 |
| Goods and Services | Education, namely, providing conferences, seminars, workshops, training, and exhibitions in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals and their development and manufacture, and the distribution of course materials in connection therewith; arrangement of conferences for educational purposes; advice relating to medical training; advisory services relating to training; advisory services relating to education; arranging and conducting of workshops in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; conducting instructional courses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; conducting of educational seminars relating to medical matters; training courses relating to medicine; training courses relating to science; medical education services, namely, providing continuing medical education courses; medical training and teaching; organisation of training courses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; publication of books; writing of texts other than publicity texts; providing continuing dental education courses; providing continuing medical education courses; provision of educational information about medical education; provision of training in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; provision of training courses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; provision of on-line electronic publications not downloadable from the Internet in the nature of newsletters, articles, e-books, and white papers in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; production of video-tapes for corporate use in corporate educational training; professional consultancy relating to education; publication of educational material in the nature of textbooks in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; training services for medical visitors in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; training services for nurses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; training services relating to health and safety; arranging and conducting of workshops relating to biologics; arranging and conducting of workshops relating to biopharmaceuticals; arranging and conducting training relating to biologics; arranging and conducting training relating to biopharmaceuticals; arrangement of workshops for educational purposes in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals |
| Goods and Services | Pharmaceutical preparations, namely, biologics and biopharmaceuticals in the form of vaccines, blood products in the nature of red blood cells, platelets, blood plasma, and blood plasma derivatives, namely, albumin, immunoglobulins and immunomodulatory factors, therapeutic proteins, gene therapy products, namely, pharmaceutical preparations for gene delivery and gene transfer for the treatment of cancers and diseases affecting the immune system, and living tissue used to protect against infectious disease and to treat cancers, rheumatoid diseases and disorders, skin diseases and disorders, immune system diseases and disorders, anemia and diseases of the blood, gastrointestinal diseases and disorders, and neurological diseases and disorders; sanitary preparations for medical purposes; plasters for medical purposes as materials for dressings; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceutical preparations and substances in the nature of vaccines and blood products in the nature of red blood cells, platelets, blood plasma, and blood plasma derivatives, namely, albumin, immunoglobulins and immunomodulatory factors, therapeutic proteins, gene therapy products, namely, pharmaceutical preparations for gene delivery and gene transfer for the treatment of cancers and diseases affecting the immune system, and living tissue; injectable pharmaceutical compositions and preparations comprising compounds having asparaginase activity for treatment of leukaemia; pharmaceutical compositions and preparations for the treatment of leukaemia and malignant diseases in the blood forming organs |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "BIOPHARMA" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, April 12, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, April 12, 2024 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | PORTON BIOPHARMA LIMITED |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | PORTON BIOPHARMA LIMITED |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | PORTON BIOPHARMA LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Friday, April 12, 2024 | CANCELLED SECTION 71 |
| Monday, September 26, 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Friday, January 26, 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, December 27, 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, December 27, 2017 | FINAL DISPOSITION PROCESSED |
| Tuesday, December 26, 2017 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, September 26, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 11, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 11, 2017 | PUBLISHED FOR OPPOSITION |
| Saturday, July 8, 2017 | NOTIFICATION PROCESSED BY IB |
| Wednesday, June 21, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 21, 2017 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, June 21, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, June 5, 2017 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, June 2, 2017 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Tuesday, May 23, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, May 5, 2017 | ASSIGNED TO EXAMINER |
| Wednesday, May 3, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, May 3, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 3, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 3, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, April 18, 2017 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
| Tuesday, April 18, 2017 | CONTINUATION OF FINAL REFUSAL E-MAILED |
| Tuesday, April 18, 2017 | ACTION CONTINUING A FINAL - COMPLETED |
| Monday, February 27, 2017 | ATTORNEY REVIEW COMPLETED |
| Monday, February 27, 2017 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, February 7, 2017 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED |
| Friday, December 23, 2016 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Friday, September 2, 2016 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, September 2, 2016 | FINAL REFUSAL E-MAILED |
| Friday, September 2, 2016 | FINAL REFUSAL WRITTEN |
| Friday, August 12, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 12, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 29, 2016 | ASSIGNED TO LIE |
| Monday, July 25, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, February 13, 2016 | REFUSAL PROCESSED BY IB |
| Monday, January 25, 2016 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, January 25, 2016 | REFUSAL PROCESSED BY MPU |
| Friday, January 22, 2016 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, January 21, 2016 | NON-FINAL ACTION WRITTEN |
| Tuesday, January 19, 2016 | ASSIGNED TO EXAMINER |
| Tuesday, January 12, 2016 | APPLICATION FILING RECEIPT MAILED |
| Thursday, January 7, 2016 | ASSIGNED TO EXAMINER |
| Thursday, January 7, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 6, 2016 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Sunday, January 3, 2016 | SN ASSIGNED FOR SECT 66A APPL FROM IB |